Search results
SK Channels as a New AAD Target
Author(s):
Arnela Saljic
,
Jordi Heijman
,
Dobromir Dobrev
Added:
1 year ago
Review Article
Author(s):
Raúl Ludeña
,
Raúl Ptaszynski Lanza
,
Ana Las Hayas
,
et al
Added:
1 month ago
Zeljko J Bosnjak
Job title: Professor of Anesthesiology and Physiology
Author
Author(s):
Harriette Van Spall
,
Mikhail Kosiborod
Added:
1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4…
View more
Levosimendan in Cardiogenic Shock
Author(s):
Hendri Susilo
,
Fan Maitri Aldian
,
Citrawati Dyah Kencono Wungu
,
et al
Added:
1 year ago
Review Article
The Coronary Microcirculation Re-explored
Author(s):
Ahmed Elamin
,
Mustafa Abdimalik
,
Mohanad Abdelrahim
,
et al
Added:
6 months ago
Review Article
Added:
2 months ago
Source:
Radcliffe CVRM
The CONFIDENCE trial investigated the efficacy of dual Empagliflozin & Finerenone therapy in compound CKD-T2D patients compared to Finerenone monotherapy in hyperkalemia prevention. The results suggested that dual therapy did not significantly mitigate hyperkalemia risk compared to solitary Finerenone administration.¹MethodologyThe CONFIDENCE trial was a double-blind, randomised, controlled study…
View more
Non-invasive Coronary Functional Tests in ANOCA
Author(s):
Nello Cambise
,
Angelo Giuseppe Marino
,
Fabio De Benedetto
,
et al
Added:
3 months ago
Original Research
Mark Tyrrell
Job title: Consultant Vascular Surgeon
Author